Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics, Offloads Meta Platforms
Novavax Told by FDA to Conduct Additional Study for COVID Vaccine - Report
Merck Gains After Latest Survival Data for Summit's Cancer Drug
Natera Announces That Its Ultra-Sensitive Signatera Genome Assay Is Now Broadly Available To Physicians In The United States.
Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps
Amphenol Posts Better-Than-Expected Results, Joins SAP, Tesla, Pegasystems And Other Big Stocks Moving Higher On Wednesday
Antelope Enterprise Regains Compliance With Nasdaq
Veracyte Says At Least 18 Abstracts Focused On Decipher Prostate And Decipher Bladder Genomic Classifiers Will Be Presented At AUA 2025
Veracyte Says Data From Decipher Prostate Genomic Classifier Are Linked to Real-World Data in NCI's SEER Specialized Database Release
How Do Investors Really Feel About Alnylam Pharmaceuticals?
Qiagen Analyst Ratings
10 Health Care Stocks Whale Activity In Today's Session
Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today
Agilent Technologies Gets European Certification For PD-L1 IHC 22C3 PharmDx To Help Gastric Or GEJ Adenocarcinoma Patients for KEYTRUDA Therapy
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
Shares of Vaccine Stocks Are Trading Lower After CDC Advisers Begins a Review of Vaccine Guidelines and Discussed a More Narrow Use of COVID-19 Booster Shots.
Legend Biotech Analyst Ratings
Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 15 Years
Green Plains Adds Three New Board Members; BofA Downgrades on Macro Headwinds
Novavax Covid Vaccine Shows Milder Side Effects Than Pfizer-BioNTech's Shot: Study